Heterozygous Dnmt3a R878C induces expansion of quiescent hematopoietic stem cell pool

Takashi Higo, Yutaro Suzuki, Michiaki Sato, Junji Koya, Hideaki Mizuno, Masashi Miyauchi, Yosuke Masamoto, Keisuke Kataoka, Yoshiki Sumitomo, Takako Tsuruta-Kishino, Tomohiko Sato, Mineo Kurokawa

研究成果: Article査読


Somatic mutation of DNMT3A (DNA methyltransferase 3 alpha) is implicated in the development of a wide range of hematological disorders, including clonal hematopoiesis of indeterminate potential. To elucidate the functional roles of endogenous levels of a DNMT3A R882 mutant, we generated a novel Dnmt3a R878C conditional knock-in mouse model. In contrast to viable heterozygotes, mice homozygous for the Dnmt3a R878C mutation in the hematopoietic system were not viable (Dnmt3a R878C is homologous to human DNMT3A R882C). Hematopoietic cell-specific heterozygous expression of Dnmt3a R878C led to significant expansion of adult quiescent hematopoietic stem cells (HSCs); however, these mice had no hematological malignancies. The expanding HSC population in heterozygous Dnmt3a R878C knock-in mice had an accumulation of G0-phase cells. In contrast to aberrantly enhanced self-renewal capacity in vitro, heterozygous Dnmt3a R878C knock-in HSCs had no competitive repopulating advantage in vivo over wild-type HSCs. Considering the capacity of the heterozygous Dnmt3a R878C mutant for HSC pool expansion, our Dnmt3a R878C knock-in mouse line is a useful platform on which to dissect the pathophysiology of clonal hematopoiesis. This mouse line can also help to elucidate the biological and molecular actions of DNMT3A mutations in the malignant transformation of normal HSCs.

ジャーナルExperimental Hematology
出版ステータスPublished - 2022 5月

ASJC Scopus subject areas

  • 分子生物学
  • 血液学
  • 遺伝学
  • 細胞生物学
  • 癌研究


「Heterozygous Dnmt3a R878C induces expansion of quiescent hematopoietic stem cell pool」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。